BackTaro Pharmaceutical Industries Overview

Taro Pharmaceutical Industries Intangible Assets

Latest intangible assets for TARO: $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00
100.00% YoYΔ $-76.14M vs prior year quarter

Peer average

Loading

Taro Pharmaceutical Industries Intangible Assets History

Loading

Taro Pharmaceutical Industries vs. peers: Intangible Assets Comparison

Loading

Taro Pharmaceutical Industries Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Taro Pharmaceutical Industries (TARO) FAQ

Taro Pharmaceutical Industries (TARO) currently reports a intangible assets of $0 as of March 2024. That compares with $76M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Taro Pharmaceutical Industries's intangible assets history and peer comparisons.

Taro Pharmaceutical Industries's intangible assets decreased from $76M to $0 — a 100.0% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Taro Pharmaceutical Industries reported $0 in intangible assets as of March 2024. That compares with $76M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Taro Pharmaceutical Industries, and consider following TARO for alerts when major investors trade the stock.

Taro Pharmaceutical Industries is classified in the Healthcare sector. On intangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TARO with unrelated industries.